Quick Answer
Forte Biosciences, Inc. reported Total Revenue of $36.0 thousand for the year ending 2019.
- Forte Biosciences, Inc. showed a decrease of -99.8% in Total Revenue from 2018 to 2019.
- This data is from Forte Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2020.
- XBRL data for this metric is available from 2016 to 2019 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $10.0 thousand | Q3 2017: $10.0 thousand | Q1 2018: $9.0 thousand | Q2 2018: $9.0 thousand | Q3 2018: $18.01 million | Q1 2019: $9.0 thousand | Q2 2019: $9.0 thousand | Q3 2019: $9.0 thousand.
- Over the full 4 years of available data (2016 to 2019), Forte Biosciences, Inc.'s Total Revenue has declined by 26.5%.
- Historical annual values: Fiscal year 2019: $36.0 thousand | Fiscal year 2018: $18.04 million | Fiscal year 2017: $41.0 thousand | Fiscal year 2016: $49.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: